Skip to main content

Table 4 Comparison of clinical response

From: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

  

pCR/mRCB

pCR

  

No

Yes

No

Yes

Clinical Response to AC

complete response

5

18

8

15

partial response

36

31

39

28

stable disease

20

2

20

2

progressive disease

2

0

2

0

  1. Clinical response to neoadjuvant AC (doxorubicin/cyclophosphamide) and pCR)/minimal RCB after subsequent neoadjuvant ixabepilone or paclitaxel in the GSE41998 TNBC cohort [26]
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us